Previous Article | Next Article 
Mol Cell Biol. 1993 January; 13(1): 320-330
Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver.
E P Sandgren,
N C Luetteke,
T H Qiu,
R D Palmiter,
R L Brinster and
D C Lee
Laboratory of Reproductive Physiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia 19104.
ABSTRACT
To characterize the effect(s) of transforming growth factor alpha (TGF alpha) during multistage carcinogenesis, we examined tumor development in pancreas and liver of transgenic mice that coexpressed TGF alpha with either viral (simian virus 40 T antigens [TAg]) or cellular (c-myc) oncogenes. In pancreas, TGF alpha itself was not oncogenic, but it nevertheless dramatically accelerated growth of tumors induced by either oncogene alone, thereby reducing the host life span up to 60%. Coexpression of TGF alpha and TAg produced an early synergistic growth response in the entire pancreas together with the more rapid appearance of preneoplastic foci. Coexpression of TGF alpha and c-myc also accelerated tumor growth in situ and produced transplantable acinar cell carcinomas whose rate of growth was TGF alpha dependent. In liver, expression of TGF alpha alone increased the incidence of hepatic cancer in aged mice. However, coexpression of TGF alpha with c-myc or TAg markedly reduced tumor latency and accelerated tumor growth. Significantly, expression of the TGF alpha and myc transgenes in hepatic tumors was induced up to 20-fold relative to expression in surrounding nonneoplastic liver, suggesting that high-level overexpression of these proteins acts as a major stimulus for tumor development. Finally, in both pancreas and liver, combined expression of TGF alpha and c-myc produced tumors with a more malignant (less differentiated) appearance than did expression of c-myc alone, consistent with an influence of TGF alpha upon the morphological character of c-myc-induced tumor progression. These findings demonstrate the importance of TGF alpha expression during multistage carcinogenesis in vivo and point to a major role for this growth factor as a potent stimulator of tumor growth.
Mol Cell Biol. 1993 January; 13(1): 320-330
This article has been cited by other articles:
-
Zhu, J., Jia, X., Xiao, G., Kang, Y., Partridge, N. C., Qin, L.
(2007). IMPLICATIONS FOR OSTEOLYTIC BONE METASTASES. J. Biol. Chem.
282: 26656-26664
[Abstract]
[Full Text]
-
Rajput, A., Koterba, A. P., Kreisberg, J. I., Foster, J. M., Willson, J. K.V., Brattain, M. G.
(2007). A Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism In vivo. Cancer Res.
67: 665-673
[Abstract]
[Full Text]
-
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., DePinho, R. A.
(2006). Genetics and biology of pancreatic ductal adenocarcinoma.. Genes Dev.
20: 1218-1249
[Abstract]
[Full Text]
-
Kalinichenko, V. V., Major, M. L., Wang, X., Petrovic, V., Kuechle, J., Yoder, H. M., Dennewitz, M. B., Shin, B., Datta, A., Raychaudhuri, P., Costa, R. H.
(2004). Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev.
18: 830-850
[Abstract]
[Full Text]
-
Awwad, R. A., Sergina, N., Yang, H., Ziober, B., Willson, J. K. V., Zborowska, E., Humphrey, L. E., Fan, R., Ko, T. C., Brattain, M. G., Howell, G. M.
(2003). The Role of Transforming Growth Factor {alpha} in Determining Growth Factor Independence. Cancer Res.
63: 4731-4738
[Abstract]
[Full Text]
-
Nicholes, K., Guillet, S., Tomlinson, E., Hillan, K., Wright, B., Frantz, G. D., Pham, T. A., Dillard-Telm, L., Tsai, S. P., Stephan, J.-P., Stinson, J., Stewart, T., French, D. M.
(2002). A Mouse Model of Hepatocellular Carcinoma : Ectopic Expression of Fibroblast Growth Factor 19 in Skeletal Muscle of Transgenic Mice. Am. J. Pathol.
160: 2295-2307
[Abstract]
[Full Text]
-
Hufnagl, K., Parzefall, W., Marian, B., Kafer, M., Bukowska, K., Schulte-Hermann, R., Grasl-Kraupp, B.
(2001). Role of transforming growth factor {alpha} and prostaglandins in preferential growth of preneoplastic rat hepatocytes. Carcinogenesis
22: 1247-1256
[Abstract]
[Full Text]
-
Sakairi, T., Kobayashi, K., Goto, K., Okada, M., Kusakabe, M., Tsuchiya, T., Sugimoto, J., Sano, F., Mutai, M.
(2001). Greater Expression of Transforming Growth Factor {alpha} and Proliferating Cell Nuclear Antigen Staining in Mouse Hepatoblastomas Than Hepatocellular Carcinomas Induced by a Diethylnitrosamine-Sodium Phenobarbital Regimen. Toxicol Pathol
29: 479-482
[Abstract]
-
Vail, M. E., Pierce, R. H., Fausto, N.
(2001). Bcl-2 Delays and Alters Hepatic Carcinogenesis Induced by Transforming Growth Factor {{alpha}}. Cancer Res.
61: 594-601
[Abstract]
[Full Text]
-
Giraud, A. S.
(2000). Lessons From Genetically Engineered Animal Models: X. Trefoil peptide and EGF receptor/ligand transgenic mice. Am. J. Physiol. Gastrointest. Liver Physiol.
278: G501-G506
[Abstract]
[Full Text]
-
Sargent, L. M., Zhou, X., Keck, C. L., Sanderson, N. D., Zimonjic, D. B., Popescu, N. C., Thorgeirsson, S. S.
(1999). Nonrandom Cytogenetic Alterations in Hepatocellular Carcinoma from Transgenic Mice Overexpressing c-Myc and Transforming Growth Factor-{alpha} in the Liver. Am. J. Pathol.
154: 1047-1055
[Abstract]
[Full Text]
-
Jiang, D., Yang, H., Willson, J. K. V., Liang, J., Humphrey, L. E., Zborowska, E., Wang, D., Foster, J., Fan, R., Brattain, M. G.
(1998). Autocrine Transforming Growth Factor alpha Provides a Growth Advantage to Malignant Cells by Facilitating Re-entry into the Cell Cycle from Suboptimal Growth States. J. Biol. Chem.
273: 31471-31479
[Abstract]
[Full Text]
-
Luetteke, N C, Phillips, H K, Qiu, T H, Copeland, N G, Earp, H S, Jenkins, N A, Lee, D C
(1994). The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.. Genes Dev.
8: 399-413
[Abstract]
Copyright © 1993 by the American Society for Microbiology. All rights reserved.